NCThinker
951 views
Rate Now: 1 2 3 4

average rating: 0.00 / 0 ratings
Created by MJC
DESCRIPTION:

Date updated:02-09-2007

Microcap Growth, high focus on biotech, fossle fuels and internet

symbol name last price % change open
  • +
  • THK
    Thk
  • $0.00
  • N/A
  • $N/A

Considerably undervalued. New Management/strategy is the right one. Expect EPS over $.35 for 07. Stock could go to $20. Last two Q's over 30% organic growth on retained biz. Hyper growth continues esp internationally and based on click fraud product

People owning THK also tend to own: AIGBEASBIDUBMRNCOFFTEKGHDX

TheStreet.com Rating: No Rating What is this?

  • +
  • NKTR
    Nektar Therapeuti
  • $8.88
  • +6.86%
  • $8.20

Despite PFE woes, Exubera will take center stage. Expect rapid growth in scripts esp once DTC ads start in 2nd half. Could be profitable by Q4, but more likely early next year. Next generation bong to leapfrog comp. Cheap stock/takeover potential

People owning NKTR also tend to own: AVCABSMLAGIXAVIDCTLMCVTXDSTI

TheStreet.com Rating: D+ What is this?

  • +
  • ALKS
    Alkermes
  • $7.70
  • -4.82%
  • $7.86

Another delivery name, will garner positive emotion as it marches toward its own inhaled insulin. Many products under development, many relationships w/majors. Good balance sheet. Cheap stock. Recent Q is cathartic

People owning ALKS also tend to own: ADCTAKAMARAYARRSAVIDAVNXBEAS

TheStreet.com Rating: C What is this?

  • +
  • PDLI
    Pdl Biopharma
  • $8.19
  • -1.92%
  • $8.23

Strong pipe and product set. Solid financials. Stock done nothing for last year since they surprise hiked R&D. Now beginning to see fruits of labors. Nice growth/profits/cashflow. Cheap stock

People owning PDLI also tend to own: AMDEXELTASRAFFXBVFAIBBHI

TheStreet.com Rating: C What is this?

  • +
  • SLXP
    Salix Pharmaceuti
  • $20.94
  • -0.66%
  • $20.74

I expect takeover here. Probably by Biogen. But buying based on cheapness, good growth, overreaction to competitive threat. 3 product label expansions/new approvals in '06. Solid growth, profits.

People owning SLXP also tend to own: ECAELNITRINDAQPWESZEWAB

TheStreet.com Rating: C What is this?

  • +
  • TRMS
    Trimeris
  • $3.57
  • -0.56%
  • $3.58

Expect takeover soon. Good growth but slashed R&D to pretty up for sale. Profitable. Excellent Fuzion sales yr 1. Strong partner

People owning TRMS also tend to own: ADCTBPCOPMOTXOMGGCLAB

TheStreet.com Rating: C What is this?

Portfolio not tracked!

Comments not available

ADD YOUR COMMENTS:

Jim Cramer's Portfolios of the Week

By Roberto Pedone Posted on Nov. 6, 2009 According to Jim Cramer, the bears are tellinginvestors six lies. On Wednesday’s “Mad Money” TV show, Cramer said if you ...

11.06.09 | 15:52 PM
'Fast Money' Portfolios of the Week

By Roberto Pedone Posted on Nov. 5, 2009 The traders on CNBC’s “Fast Money” told their viewers what they must know after Warren Buffett announced on Tuesday his l...

11.05.09 | 12:05 PM
Squeezing the Shorts: Late Earni...

By Jonas Elmerraji Posted on Nov. 4, 2009 For investors who seek out short-squeeze opportunities, there’s no time as important as earnings season. Earnings are one of...

11.04.09 | 15:18 PM
Cramer's Take on Headline Stocks...

By Stockpickr Staff Posted on Nov. 4, 2009 Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about it. The key is...

11.04.09 | 11:12 AM
more articles
Banjo's Garden Pic Thread
05.10.09 | 12:33 PM From author banjoman
General market Technical Analysi...
11.14.07 | 22:55 PM From author ZA
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
BIOTECH
07.26.09 | 11:32 AM From author CallaLilly
more forums
today 's lists
Analyst Downgrades

Analyst Downgrades for Nov. 2, 2009. Read more here. more

52-Week Lows

Here is a list of some of the biggest stocks that hit 52-week lows on Nov. 2, 2009. more

52-Week Highs

Here are some of the biggest stocks that made the 52-week high list on Nov. 2, 2009. more